Choroid Diseases - 25 Studies Found
Recruiting |
: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization : Choroidal Neovascularization : 2016-08-21 : Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Recruiting |
: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization : Idiopathic Choroidal Neovascularization : 2016-07-27 : Drug: conbercept 0.05ml conbercept Other Name: conbe |
Recruiting |
: Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA). : Inflammatory Choroidal Neovascularization : 2015-09-18 : Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |
Recruiting |
: Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) : Type 3 Choroidal Neovascularization : 2014-12-10 : Drug: Aflibercept |
Recruiting |
: Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization : Choroidal Neovascularization : 2014-10-06 : Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Administration by intravitreal injection |